Skip to main content
Top

Hereditary Cancer in Clinical Practice

Issue 1/2011

Content (12 Articles)

Open Access Case report

Primary appendiceal mucinous adenocarcinoma in two first-degree relatives: case report and review

Adrianne R Racek, Kari G Rabe, Myra J Wick, Apostolos Psychogios, Noralane M Lindor

Open Access Research

Factors Influencing Cancer Risk Perception in High Risk Populations: A Systematic Review

Jon C Tilburt, Katherine M James, Pamela S Sinicrope, David T Eton, Brian A Costello, Jantey Carey, Melanie A Lane, Shawna L Ehlers, Patricia J Erwin, Katherine E Nowakowski, Mohammad H Murad

Open Access Case report

Case report: BRCA in the Ashkenazi population: are current testing guidelines too exclusive?

Katherine H Saunders, Shivani Nazareth, Peter I Pressman

Open Access Research

Risk perception among Brazilian individuals with high risk for colorectal cancer and colonoscopy

Erika M Santos, Maria TC Lourenço, Benedito M Rossi

Open Access Research

Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas

Giovanni Ponti, Lorena Losi, Davide Martorana, Manuela Priola, Elisa Boni, Annamaria Pollio, Tauro Maria Neri, Stefania Seidenari

Open Access Review

Drug therapy for hereditary cancers

Evgeny N Imyanitov, Vladimir M Moiseyenko

Open Access Research

Lynch syndrome: barriers to and facilitators of screening and disease management

Kathy E Watkins, Christine Y Way, Jacqueline J Fiander, Robert J Meadus, Mary Jane Esplen, Jane S Green, Valerie C Ludlow, Holly A Etchegary, Patrick S Parfrey

Open Access Research

Molecular study of the perforin gene in familial hematological malignancies

Rim El Abed, Violaine Bourdon, Ilia Voskoboinik, Halima Omri, Yosra Ben Youssef, Mohamed Adnene Laatiri, Laetitia Huiart, François Eisinger, Laetitia Rabayrol, Marc Frenay, Paul Gesta, Liliane Demange, Hélène Dreyfus, Valérie Bonadona, Catherine Dugast, Hélène Zattara, Laurence Faivre, Monia Zaier, Saloua Yacoub Jemni, Testsuro Noguchi, Hagay Sobol, Zohra Soua

Open Access Research

Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests

Marielle AE Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, Fiona Lennard, Paul Pharoah, Ian Jacobs, Ann Ward, Desmond PJ Barton, Thomas EJ Ind, John H Shepherd, Jane E Bridges, Martin Gore, Chris Haracopos, Susan Shanley, Audrey Ardern-Jones, Sarah Thomas, Ros Eeles

Open Access Research

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece

Chrissovaladis Koumpis, Constantine Dimitrakakis, Aris Antsaklis, Robert Royer, Shiyu Zhang, Steven A Narod, Joanne Kotsopoulos

Open Access Research

Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome

Ingrid P Ewald, Patrícia Izetti, Fernando R Vargas, Miguel AM Moreira, Aline S Moreira, Carlos A Moreira-Filho, Danielle R Cunha, Sara Hamaguchi, Suzi A Camey, Aishameriane Schmidt, Maira Caleffi, Patrícia Koehler-Santos, Roberto Giugliani, Patricia Ashton-Prolla

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine